Id-1: Regulator of EGFR and VEGF and potential target for colorectal cancer therapy
<p>Abstract</p> <p>Background</p> <p>The helix-loop-helix transcription factor Id-1 (an inhibitor of differentiation and DNA binding) plays a role in development and progression of many tumours. Id-1 is known to exert its effects on the epidermal growth factor receptor...
Main Authors: | Meydan Nezih, Meteoglu Ibrahim, Erkus Muhan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-11-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/27/1/69 |
Similar Items
-
NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues
by: Erkus Muhan, et al.
Published: (2008-10-01) -
Nuclear Factor Kappa B, Matrix Metalloproteinase-1, p53, and Ki-67 Expressions in the Primary Tumors and the Lymph Node Metastases of Colorectal Cancer Cases
by: Ibrahim Meteoglu, et al.
Published: (2015-01-01) -
Simultaneous Detection of EGFR and VEGF in Colorectal Cancer using Fluorescence-Raman Endoscopy
by: Yong-il Kim, et al.
Published: (2017-04-01) -
Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
by: Li Kuiyuan, et al.
Published: (2009-04-01) -
Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer
by: Qiu TZ, et al.
Published: (2018-01-01)